NYSE Euronext Announces Trading Volumes for February 2011

Back

Global Derivatives Averaged 8.9 Million Contracts per Day in February, Up 8% vs. Prior Year
U.S Equity Options Volumes Up 33%; European Derivatives (Ex. Bclear) Up 1%
European Cash Trading Volumes Up 23%, U.S. Cash Down 14%

March 4, 2011 - NYSE Euronext (NYX) today announced trading volumes for its global derivatives and cash equities exchanges for February 2011 . Global derivatives average daily volume ("ADV") of 8.9 million contracts traded per day in February 2011 increased 7.8% versus the prior year. The increase in global derivatives ADV versus prior year levels was driven primarily by a 33.4% increase in U.S. equity options ADV, partially offset by a 9.8% decrease in European derivatives ADV. Cash equities ADV in February 2011 was mixed, with European cash ADV increasing 22.9% and U.S. cash trading volumes decreasing 13.7% from February 2010 levels.

Highlights

  • NYSE Euronext global derivatives ADV in February 2011 of 8.9 million contracts increased 7.8% compared to February 2010, but decreased 1.1% from January 2011 levels.
  • NYSE Euronext European derivatives products ADV in February 2011 of 4.4 million contracts decreased 9.8% compared to February 2010 and decreased 5.8% from January 2011 levels. Excluding Bclear, NYSE Liffe's trade administration and clearing service for OTC products, European derivatives products ADV increased 1.5% compared to February 2010 and increased 5.6% from January 2011. Total European fixed income products ADV in February 2011 of 2.8 million contracts increased 1.3% compared to February 2010 and increased 7.3% from January 2011. Total equity products ADV of 1.5 million contracts in February 2011 decreased 26.6% compared to February 2010 and decreased 23.8% from January 2011. Total commodities products ADV of 87,000 contracts in February 2011 increased 61.3% compared to February 2010.
  • NYSE Euronext U.S. equity options (NYSE Arca and NYSE Amex) ADV of 4.5 million contracts in February 2011 increased 33.4% compared to February 2010 levels and increased 4.0% from January 2011. NYSE Euronext's U.S. options exchanges accounted for 25.9% of total U.S. consolidated equity options trading in February 2011, down from 26.9% in February 2010, but up from 24.5% recorded in January 2011.
  • NYSE Euronext European cash products ADV of 1.8 million transactions in February 2011 increased 22.9% compared to February 2010 and increased slightly from January 2011 levels.
  • NYSE Euronext U.S. cash products (NYSE, NYSE Arca and NYSE Amex) handled ADV of 2.2 billion shares in February 2011 decreased 13.7% compared to February 2010 and decreased 5.3% compared to January 2011. NYSE Euronext's Tape A matched market share in February 2011 was 34.5%, down from 36.6% in February 2010, but up from 33.9% in January 2011.
  • There were a total of 20 trading days in Europe and 19 trading days in the U.S. in both February 2011 and February 2010.

Derivatives Trading - European Derivatives  

  • NYSE Euronext European derivatives products ADV in February 2011 was 4.4 million futures and options contracts, a decrease of 9.8% from February 2010 and a decrease of 5.8% from January 2011. The 4.4 million in futures and options contracts ADV in February 2011 consisted of 3.9 million contracts executed through our full-service LIFFE CONNECT trading platform and 0.5 million contracts, or 10.7%, executed through Bclear, NYSE Liffe's trade administration and clearing service for OTC products. Excluding Bclear, European derivatives products ADV increased 1.5% compared to February 2010 and increased 5.6% from January 2011.
  • Year-to-date, European derivatives products ADV of 4.6 million contracts was 8.6% below prior year levels. The 4.6 million in futures and options contracts ADV year-to-date consisted of 3.8 million contracts executed through the LIFFE CONNECT trading platform and 0.7 million contracts, or 15.8%, executed through Bclear.
  • Total fixed income products ADV of 2.8 million contracts in February 2011 increased 1.3% from February 2010 and increased 7.3% from January 2011. Year-to-date, total fixed income products ADV of 2.7 million contracts was 1.6% below prior year levels.
  • Total equity products (including Bclear) ADV of 1.5 million contracts in February 2011 decreased 26.6% compared to February 2010 and decreased 23.8% from January 2011. The 1.5 million contracts in equity products ADV consisted of 1.0 million contracts in individual equity products ADV and 0.5 million contracts in equity index products ADV. The 1.0 million contracts in individual equity products ADV consisted of 0.3 million in futures contracts, which represented a 61.6% decrease compared to February 2010 and 0.7 million in options contracts, which represented an 8.9% increase compared to February 2010. The average net rate per contract for individual equity futures contracts is significantly lower than other products traded on NYSE Liffe. Year-to-date, total equity products ADV of 1.8 million contracts was 19.0% below prior year levels.
  • Total commodities products ADV of 87,000 contracts in February 2011 increased 61.3% compared to February 2010. Year-to-date, total commodities product ADV of 80,000 contracts was 54.5% above prior year levels.

U.S. Derivatives

  • NYSE Euronext U.S. equity options (NYSE Arca and NYSE Amex) ADV of 4.5 million contracts in February 2011 increased 33.4% compared to February 2010 and increased 4.0% compared to January 2011. Year-to-date, U.S. equity options ADV of 4.4 million contracts was 16.5% above prior year levels.
  • Total U.S. consolidated equity options ADV increased 38.4% to 17.5 million contracts in February 2011 compared to February 2010, but decreased 1.5% compared to January 2011. Year-to-date, U.S. consolidated equity options ADV of 17.6 million contracts was 26.5% above prior year levels.
  • NYSE Euronext's U.S. options exchanges accounted for 25.9% of the total U.S. consolidated equity options trading in February 2011, down from 26.9% in February 2010, but up from 24.5% in January 2011.
  • NYSE Euronext U.S. futures and futures options (NYSE Liffe U.S.) ADV in February 2011 was approximately 12,900 contracts, compared to 22,500 contracts in February 2010. Year-to-date U.S. futures and futures options ADV was 13,600 contracts, a decrease of 39.3% compared to the prior year period.

Press Release Footer

About Euronext 
Euronext is the leading pan-European market infrastructure, connecting European economies to global capital markets, to accelerate innovation and sustainable growth. It operates regulated exchanges in Belgium, France, Ireland, Italy, the Netherlands, Norway and Portugal. With close to 2,000 listed issuers and around €5.8 trillion in market capitalisation as of end June 2022, it has an unmatched blue-chip franchise and a strong diverse domestic and international client base. Euronext operates regulated and transparent equity and derivatives markets, one of Europe’s leading electronic fixed income trading markets and is the largest centre for debt and funds listings in the world. Its total product offering includes Equities, FX, Exchange Traded Funds, Warrants & Certificates, Bonds, Derivatives, Commodities and Indices. The Group provides a multi-asset clearing house through Euronext Clearing, and custody and settlement services through Euronext Securities central securities depositories in Denmark, Italy, Norway and Portugal. Euronext also leverages its expertise in running markets by providing technology and managed services to third parties. In addition to its main regulated market, it also operates a number of junior markets, simplifying access to listing for SMEs.  
For the latest news, follow us on Twitter (twitter.com/euronext) and LinkedIn (linkedin.com/euronext).

Disclaimer
This press release is for information purposes only and is not a recommendation to engage in investment activities. This press release is provided “as is” without representation or warranty of any kind. While all reasonable care has been taken to ensure the accuracy of the content, Euronext does not guarantee its accuracy or completeness. Euronext will not be held liable for any loss or damages of any nature ensuing from using, trusting or acting on information provided. No information set out or referred to in this publication may be regarded as creating any right or obligation. The creation of rights and obligations in respect of financial products that are traded on the exchanges operated by Euronext’s subsidiaries shall depend solely on the applicable rules of the market operator. All proprietary rights and interest in or connected with this publication shall vest in Euronext.

This press release speaks only as of this date. Euronext refers to Euronext N.V. and its affiliates. Information regarding trademarks and intellectual property rights of Euronext is located at www.euronext.com/terms-use.

© 2022, Euronext N.V. - All rights reserved.